Colorectal carcinogenesis--update and perspectives.
暂无分享,去创建一个
Jacob Rosenberg | Jakob Burcharth | Hans-Christian Pommergaard | H. Pommergaard | J. Rosenberg | J. Burcharth | Hans Raskov | H. Raskov
[1] J. Lysaght,et al. Eicosanoid signalling pathways in the development and progression of colorectal cancer: novel approaches for prevention/intervention , 2011, Cancer and Metastasis Reviews.
[2] W. El-Deiry,et al. Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[3] Swee Lay Thein,et al. Hypervariable ‘minisatellite’ regions in human DNA , 1985, Nature.
[4] C. Franceschi,et al. Immunosenescence and Immunogenetics of Human Longevity , 2008, Neuroimmunomodulation.
[5] A. Duval,et al. Diagnostic criteria for constitutional mismatch repair deficiency syndrome: suggestions of the European consortium ‘Care for CMMRD’ (C4CMMRD) , 2014, Journal of Medical Genetics.
[6] P. Parfrey,et al. Association of total energy intake and macronutrient consumption with colorectal cancer risk: results from a large population-based case-control study in Newfoundland and Labrador and Ontario, Canada , 2012, Nutrition Journal.
[7] P. Edwards. The Impact of Developmental Biology on Cancer Research: An Overview , 2004, Cancer and Metastasis Reviews.
[8] E. Nevo,et al. Microsatellites: genomic distribution, putative functions and mutational mechanisms: a review , 2002, Molecular ecology.
[9] H. Bernstein,et al. Bile acids as endogenous etiologic agents in gastrointestinal cancer. , 2009, World journal of gastroenterology.
[10] F. Guarner,et al. Linking the gut microbiota to human health , 2013, British Journal of Nutrition.
[11] J. Muir,et al. Resistant starch lowers fecal concentrations of ammonia and phenols in humans. , 1996, The American journal of clinical nutrition.
[12] R. Rosenblatt. Human Health and Disease , 2002 .
[13] J. Yates,et al. α-Catenin interacts with APC to regulate β-catenin proteolysis and transcriptional repression of Wnt target genes , 2013, Genes & development.
[14] W. Scheithauer,et al. Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study , 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] E. Wynder,et al. Large-bowel carcinogenesis: fecal constituents of populations with diverse incidence rates of colon cancer. , 1973, Journal of the National Cancer Institute.
[16] L. Schwartz,et al. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[17] S. Glaser,et al. Mechanisms for nicotine in the development and progression of gastrointestinal cancers. , 2012, Translational gastrointestinal cancer.
[18] G. Macfarlane,et al. Short chain fatty acids in human large intestine, portal, hepatic and venous blood. , 1987, Gut.
[19] Dawn Mazzatti,et al. Aging of the immune system as a prognostic factor for human longevity. , 2008, Physiology.
[20] K. Nelson,et al. Microbiome in Human Health and Disease , 2013, Science progress.
[21] Guoping Zheng,et al. E-Cadherin/β-Catenin Complex and the Epithelial Barrier , 2011, Journal of biomedicine & biotechnology.
[22] J. Greenman,et al. Clinical utility of anti-p53 auto-antibody: systematic review and focus on colorectal cancer. , 2013, World journal of gastroenterology.
[23] M. Comănescu,et al. K-ras gene mutation status in colorectal cancer: comparative analysis of pyrosequencing and PCR-RFLP. , 2013, Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie.
[24] J. Petrosino,et al. The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.
[25] Sudhir Srivastava,et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.
[26] E. Martens,et al. How glycan metabolism shapes the human gut microbiota , 2012, Nature Reviews Microbiology.
[27] Xavier Duval,et al. Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. , 2009, Human pathology.
[28] B. Leggett,et al. Role of the serrated pathway in colorectal cancer pathogenesis. , 2010, Gastroenterology.
[29] G. Grosso,et al. Pharmacological and dietary prevention for colorectal cancer , 2013, BMC Surgery.
[30] Richard Bowman,et al. Red meat enhances the colonic formation of the DNA adduct O6-carboxymethyl guanine: implications for colorectal cancer risk. , 2006, Cancer research.
[31] T. Bekaii-Saab,et al. Integrating anti-EGFR therapies in metastatic colorectal cancer. , 2013, Journal of gastrointestinal oncology.
[32] F. Pierre,et al. Heme Iron from Meat and Risk of Colorectal Cancer: A Meta-analysis and a Review of the Mechanisms Involved , 2011, Cancer Prevention Research.
[33] M. Vatn,et al. Fatty Acids in Habitual Diet, Plasma Phospholipids, and Tumour and Normal Colonic Biopsies in Young Colorectal Cancer Patients , 2012, Journal of oncology.
[34] E. Riboli,et al. The second expert report, Food, Nutrition, Physical Activity and the Prevention of Cancer: A Global Perspective , 2007 .
[35] Lawrence A. David,et al. Diet rapidly and reproducibly alters the human gut microbiome , 2013, Nature.
[36] A. J. Leonel,et al. Butyrate: implications for intestinal function , 2012, Current opinion in clinical nutrition and metabolic care.
[37] Y. Tzeng,et al. Synthesis and biological evaluation of 3',4',5'-trimethoxychalcone analogues as inhibitors of nitric oxide production and tumor cell proliferation. , 2009, Bioorganic & medicinal chemistry.
[38] H. Lynch,et al. Dawning of the epigenetic era in hereditary cancer , 2014, Clinical genetics.
[39] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[40] D. Alexander,et al. Meta‐Analysis of Prospective Studies of Red Meat Consumption and Colorectal Cancer , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[41] H. Pyo,et al. Cyclooxygenase-2 (COX-2) Negatively Regulates Expression of Epidermal Growth Factor Receptor and Causes Resistance to Gefitinib in COX-2–Overexpressing Cancer Cells , 2009, Molecular Cancer Research.
[42] W. Hasler,et al. Inhibitory actions of a high fibre diet on intestinal gas transit in healthy volunteers , 2004, Gut.
[43] B. Shatenstein,et al. Specific fatty acids and human colorectal cancer: an overview. , 2003, Cancer detection and prevention.
[44] S. Roberts,et al. Measurement of in vivo proliferation in human colorectal mucosa using bromodeoxyuridine. , 1992, Gut.
[45] V. Tremaroli,et al. Functional interactions between the gut microbiota and host metabolism , 2012, Nature.
[46] Ya‐Wen Cheng,et al. Human papilloma virus 16 E6 oncoprotein associated with p53 inactivation in colorectal cancer. , 2012, World journal of gastroenterology.
[47] Rui Zhao,et al. Patterns of Proliferative Activity in the Colonic Crypt Determine Crypt Stability and Rates of Somatic Evolution , 2013, PLoS Comput. Biol..
[48] H. Morreau,et al. MUTYH-associated polyposis (MAP). , 2011, Critical reviews in oncology/hematology.
[49] H. Bernstein,et al. Hydrophobic bile acids, genomic instability, Darwinian selection, and colon carcinogenesis , 2008, Clinical and experimental gastroenterology.
[50] E. Levin,et al. Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: Insight into mechanisms and implications for cancer growth and ulcer healing , 1999, Nature Medicine.
[51] W. Grady,et al. Genomic and epigenetic instability in colorectal cancer pathogenesis. , 2008, Gastroenterology.
[52] A. Krasinskas. EGFR Signaling in Colorectal Carcinoma , 2011, Pathology research international.
[53] A. Taylor,et al. Fecal steroids and urinary volatile phenols in four Scandinavian populations. , 1982, Nutrition and cancer.
[54] H. Bernstein,et al. Hydrophobic Bile Acid-Induced Micronuclei Formation, Mitotic Perturbations, and Decreases in Spindle Checkpoint Proteins: Relevance to Genomic Instability in Colon Carcinogenesis , 2010, Nutrition and cancer.
[55] V. Colantuoni,et al. Genetic and Epigenetic Events Generate Multiple Pathways in Colorectal Cancer Progression , 2012, Pathology research international.
[56] Joana M. Xavier,et al. The role of p53 in apoptosis. , 2010, Discovery medicine.
[57] Tannaz Armaghany,et al. Genetic alterations in colorectal cancer. , 2012, Gastrointestinal cancer research : GCR.
[58] Martin Wiseman,et al. The Second World Cancer Research Fund/American Institute for Cancer Research Expert Report. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective , 2008, Proceedings of the Nutrition Society.
[59] Kay Washington,et al. Molecular testing in colorectal cancer: diagnosis of Lynch syndrome and personalized cancer medicine. , 2012, American journal of clinical pathology.
[60] J. Jass. Pathogenesis of colorectal cancer. , 2002, The Surgical clinics of North America.
[61] B. Drasar,et al. Faecal steroids and bacteria and large bowel cancer in Hong Kong by socio-economic groups. , 1976, British Journal of Cancer.
[62] W. Chey,et al. Fiber and Functional Gastrointestinal Disorders , 2013, The American Journal of Gastroenterology.
[63] V. Heinemann,et al. Clinical relevance of EGFR- and KRAS-status in colorectal cancer patients treated with monoclonal antibodies directed against the EGFR. , 2009, Cancer treatment reviews.
[64] Takuji Tanaka,et al. Selective PGE2 Suppression Inhibits Colon Carcinogenesis and Modifies Local Mucosal Immunity , 2011, Cancer Prevention Research.
[65] M. Verma,et al. Epigenetics of colon cancer. , 2012, Methods in molecular biology.
[66] P. Sansonetti,et al. To be or not to be a pathogen: that is the mucosally relevant question , 2011, Mucosal Immunology.
[67] R. Sinha,et al. A large prospective study of meat consumption and colorectal cancer risk: an investigation of potential mechanisms underlying this association. , 2010, Cancer research.
[68] I. Rowland. The role of the gastrointestinal microbiota in colorectal cancer. , 2009, Current pharmaceutical design.
[69] P. Maisonneuve,et al. Smoking and colorectal cancer: a meta-analysis. , 2008, JAMA.
[70] R. Lau,et al. Dietary fibre, whole grains, and risk of colorectal cancer: systematic review and dose-response meta-analysis of prospective studies , 2011, BMJ : British Medical Journal.
[71] Kathleen R. Cho,et al. Mutant KRAS promotes hyperplasia and alters differentiation in the colon epithelium but does not expand the presumptive stem cell pool. , 2011, Gastroenterology.
[72] S. Lowe,et al. Tumor suppressive functions of p53. , 2009, Cold Spring Harbor perspectives in biology.
[73] Adenomatous Polyposis Coli , 2013 .
[74] Harald zur Hausen,et al. Red meat consumption and cancer: Reasons to suspect involvement of bovine infectious factors in colorectal cancer , 2012 .
[75] M. Sideris,et al. Molecular biomarkers and classification models in the evaluation of the prognosis of colorectal cancer. , 2014, Anticancer research.
[76] Chuanshu Huang,et al. Inflammation, a Key Event in Cancer Development , 2006, Molecular Cancer Research.
[77] A. Qian,et al. Dietary fiber intake reduces risk for colorectal adenoma: a meta-analysis. , 2014, Gastroenterology.
[78] Tomas Lindahl,et al. Repair and genetic consequences of endogenous DNA base damage in mammalian cells. , 2004, Annual review of genetics.
[79] Kang-Yell Choi,et al. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling. , 2014, Journal of the National Cancer Institute.
[80] Viji M. Draviam,et al. Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1‐ or APC‐depleted cells , 2006, The EMBO journal.
[81] M. Arends,et al. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome , 2010, Histopathology.
[82] M. Stockler,et al. Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[83] Cassandra Willyard. Microbiome: Gut reaction , 2011, Nature.
[84] Paolo Vineis,et al. Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study , 2003, The Lancet.
[85] Sofie Mellberg. Molecular Regulation of Angiogenesis , 2008 .
[86] Y. Yarden,et al. EGF receptor family: twisting targets for improved cancer therapies , 2014, Growth factors.
[87] Michael Karin,et al. Inflammation and colon cancer. , 2010, Gastroenterology.
[88] H T Lynch,et al. Hereditary colorectal cancer. , 1991, Seminars in oncology.
[89] K. Kinzler,et al. Cancer genes and the pathways they control , 2004, Nature Medicine.
[90] Sang-Uk Seo,et al. Role of the gut microbiota in immunity and inflammatory disease , 2013, Nature Reviews Immunology.
[91] R. B. Richardson. p53 mutations associated with aging-related rise in cancer incidence rates , 2013, Cell cycle.
[92] G. Tortora,et al. A novel approach in the treatment of cancer: targeting the epidermal growth factor receptor. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[93] Josep Tabernero,et al. EGFR and KRAS in colorectal cancer. , 2010, Advances in clinical chemistry.
[94] R. Goldbohm,et al. APC mutations in sporadic colorectal carcinomas from The Netherlands Cohort Study. , 2004, Carcinogenesis.
[95] P. Propping,et al. MUTYH‐associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype , 2006, International journal of cancer.
[96] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[97] Aung Ko Win,et al. Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis , 2011, Familial Cancer.
[98] Kazufumi Suzuki,et al. Recent Advances in p53 Research and Cancer Treatment , 2011, Journal of biomedicine & biotechnology.
[99] F. Clavel-Chapelon,et al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study , 2011, BMJ : British Medical Journal.
[100] G. Cooper. The Cell: A Molecular Approach , 1996 .
[101] E. Riboli,et al. Alcohol intake and colorectal cancer risk: A dose–response meta‐analysis of published cohort studies , 2007, International journal of cancer.
[102] D. Evans,et al. Increased colorectal cancer incidence in obligate carriers of heterozygous mutations in MUTYH. , 2009, Gastroenterology.
[103] J. Lasa,et al. Intestinal Microbiota: Its Role in Digestive Diseases , 2014, Journal of clinical gastroenterology.
[104] T. Wang,et al. Bacteria Deliver a Genotoxic Hit , 2012, Science.
[105] K. Alitalo,et al. Molecular regulation of angiogenesis and lymphangiogenesis , 2007, Nature Reviews Molecular Cell Biology.
[106] D. Alexander,et al. Processed meat and colorectal cancer: a quantitative review of prospective epidemiologic studies , 2010, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[107] R. Flavell,et al. Interchromosomal associations between alternatively expressed loci , 2005, Nature.
[108] B. Leggett,et al. Colorectal carcinogenesis: road maps to cancer. , 2007, World journal of gastroenterology.
[109] W. Willett,et al. Alcohol Intake and Colorectal Cancer: A Pooled Analysis of 8 Cohort Studies , 2004, Annals of Internal Medicine.
[110] T. Frebourg,et al. Molecular determinants of anti-EGFR sensitivity and resistance in metastatic colorectal cancer , 2010, British Journal of Cancer.
[111] J. Massagué,et al. Epidermal growth factor signaling via Ras controls the Smad transcriptional co‐repressor TGIF , 2001, The EMBO journal.
[112] J. Goedert,et al. Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.
[113] H. Tajiri,et al. High frequency of K-ras mutations in human colorectal hyperplastic polyps. , 1997, Gut.
[114] Ali H. Sayed,et al. Post-translational regulation enables robust p53 regulation , 2013, BMC Systems Biology.
[115] B. Leggett,et al. The serrated pathway to colorectal carcinoma: current concepts and challenges , 2013, Histopathology.
[116] G. Montgomery,et al. Microsatellite Stable Colorectal Cancers Stratified by the BRAF V600E Mutation Show Distinct Patterns of Chromosomal Instability , 2014, PloS one.
[117] A. Bahnassy,et al. Differential expression of p53 family proteins in colorectal adenomas and carcinomas: Prognostic and predictive values. , 2014, Histology and Histopathology.
[118] A. Araújo,et al. Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives. , 2013, World journal of gastroenterology.
[119] J. Carethers. Differentiating Lynch-like from Lynch syndrome. , 2014, Gastroenterology.
[120] S. Bultman,et al. Emerging roles of the microbiome in cancer. , 2014, Carcinogenesis.
[121] C. Blanpain. Tracing the cellular origin of cancer , 2013, Nature Cell Biology.
[122] B. Simi,et al. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. , 1980, The Journal of nutrition.
[123] S. Ehrlich,et al. Replication slippage involves DNA polymerase pausing and dissociation , 2001, The EMBO journal.
[124] J. Sweasy,et al. A DNA polymerase β mutant from colon cancer cells induces mutations , 2004 .
[125] J. Barnholtz-Sloan,et al. Dietary fatty acids, luminal modifiers, and risk of colorectal cancer , 2010, International journal of cancer.
[126] A. Laner,et al. MUTYH‐associated polyposis – variability of the clinical phenotype in patients with biallelic and monoallelic MUTYH mutations and report on novel mutations , 2010, Clinical genetics.
[127] B. Drasar,et al. Bacteria and aetiology of cancer of large bowel. , 1971, Lancet.
[128] L. Cosgrove,et al. Colorectal Carcinogenesis: A Cellular Response to Sustained Risk Environment , 2013, International journal of molecular sciences.
[129] Neal J Meropol,et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[130] Hans Clevers,et al. Crypt stem cells as the cells-of-origin of intestinal cancer , 2009, Nature.
[131] Bas E Dutilh,et al. A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects , 2012, Nature Reviews Microbiology.
[132] M. Taketo,et al. Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene , 2007, Journal of Cell Science.
[133] J. Gisbert,et al. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[134] Sadir J Alrawi,et al. Aberrant crypt foci. , 2006, Anticancer research.
[135] R. Fodde,et al. The role of the APC tumor suppressor in chromosomal instability. , 2006, Genome dynamics.
[136] D. van Heemst,et al. Ageing or cancer: a review on the role of caretakers and gatekeepers. , 2007, European journal of cancer.
[137] S. Rampelli,et al. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. , 2014, World journal of gastroenterology.
[138] J. Doré,et al. The inflammatory status of old age can be nurtured from the intestinal environment , 2008, Current opinion in clinical nutrition and metabolic care.
[139] M. Dewhirst. Relationships between Cycling Hypoxia, HIF-1, Angiogenesis and Oxidative Stress , 2009, Radiation research.
[140] W F Bodmer,et al. The ABC of APC. , 2001, Human molecular genetics.
[141] B. Ponder,et al. Use of A Mouse Chimaeric Model to Study Cell Migration Patterns In the Small Intestinal Epithelium , 1985, Cell and tissue kinetics.
[142] M. Peppelenbosch,et al. Biological effects of propionic acid in humans; metabolism, potential applications and underlying mechanisms. , 2010, Biochimica et biophysica acta.
[143] H. Kitano,et al. A comprehensive pathway map of epidermal growth factor receptor signaling , 2005, Molecular systems biology.
[144] Pat Baird,et al. Health benefits of dietary fiber. , 2009, Nutrition reviews.
[145] P. Carmeliet,et al. Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis , 1998, Nature.
[146] David M. Thomas,et al. Li-Fraumeni syndrome: cancer risk assessment and clinical management , 2014, Nature Reviews Clinical Oncology.
[147] L. Påhlman,et al. Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery. , 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.